Lorenzo Tallarigo, Director at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 2,007 shares at $258.20 ($511K) on 2014-05-07, disclosed to the SEC on 2014-05-09.
Scheduled sale ($511k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $258.20 | 640 | $165K | 32.3% |
| 2 | $260.76 | 1,000 | $261K | 51.0% |
| 3 | $232.00 | 367 | $85K | 16.7% |
| Total | $254.68 avg | 2,007 | $511K | 100% |
| Filing → |
| ICPT | SELL | 2014-02-11 | $130K | — | Filing → |
| ICPT | SELL | 2014-01-09 | $124K | — | Filing → |
| ICPT | SELL | 2013-10-23 | $7.8M | — | Filing → |